[1]
Blasko, G.; Cordell, G.A. Isolation, Structure Elucidation, and Biosynthesis of The Bisindole Alkaloids of Catharanthus. In:The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic Press: New York, 1990, Vol. 37, pp. 1-240.
[2]
Pezzuto, J.M. Plant-derived anticancer agents. Biochem. Pharmacol., 1997, 53(2), 121-133.
[3]
Ehrhardt, H.; Pannert, L.; Pfeiffer, S.; Wachter, F.; Amtmann, E.; Jeremias, I. Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies. Br. J. Pharmacol., 2013, 168(7), 1558-1569.
[4]
Mukhtar, E.; Adhami, V.M.; Mukhtar, H. Targeting microtubules by natural agents for cancer therapy. Mol. Cancer Ther., 2014, 13(2), 275-284.
[5]
Wang, Y.; Benz, F.W.; Wu, Y.; Wang, Q.; Chen, Y.; Chen, X.; Li, H.; Zhang, Y.; Zhang, R.; Yang, J. Structural insights into the pharmacophore of vinca domain inhibitors of microtubules. Mol. Pharmacol., 2016, 89(2), 233-242. [http://dx.doi.org/10.1124/mol.115.100149]. [PMID: 26660762].
[6]
Moudi, M.; Go, R.; Yien, C.Y.; Nazre, M. Vinca alkaloids. Int. J. Prev. Med., 2013, 4(11), 1231-1235.
[7]
Jordan, M.A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 2004, 4(4), 253-265.
[8]
Keglevich, P.; Hazai, L.; Dubrovay, Zs.; Sánta, Zs.; Dékány, M.; Szántay, Cs., Jr; Kalaus, Gy.; Szántay, Cs. Bisindole alkaloids condensed with a cyclopropane ring, part 2. cyclopropano-vinorelbine and its derivatives. Heterocycles, 2015, 90(1), 316-326.
[9]
Hu, L.; Song, W.; Meng, Y.; Guo, D.; Liu, X.; Hu, L. Synthesis and structure-activity relationship studies of cytotoxic vinorelbine amide analogues. Bioorg. Med. Chem. Lett., 2012, 22(24), 7547-7550.
[10]
Keglevich, A.; Mayer, S.; Pápai, R.; Szigetvári, Á.; Sánta, Z.; Dékány, M.; Szántay, C., Jr; Keglevich, P.; Hazai, L. Attempted synthesis of vinca alkaloids condensed with three-membered rings. Molecules, 2018, 23(10), 2574-2594.
[11]
Keglevich, P.; Hazai, L.; Kalaus, G.; Szántay, C. Modifications on the basic skeletons of vinblastine and vincristine. Molecules, 2012, 17(5), 5893-5914.
[12]
Nepali, K.; Sharma, S.; Sharma, M.; Bedi, P.M.S.; Dhar, K.L. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur. J. Med. Chem., 2014, 77, 422-487.
[13]
Decker, M. Design of Hybrid Molecules for Drug Development, 1st ed; Elsevier Ltd.: Oxford, 2017.
[14]
Choudhary, S.; Singh, P.K.; Verma, H.; Singh, H.; Silakari, O. Success stories of natural product-based hybrid molecules for multi-factorial diseases. Eur. J. Med. Chem., 2018, 151, 62-97.
[15]
Shaveta.; Mishra, S.; Singh, P. Hybrid molecules: The privileged scaffolds for various pharmaceuticals. Eur. J. Med. Chem., 2016, 124, 500-536.
[16]
Decker, M. Hybrid molecules incorporating natural products: Applications in cancer therapy, neurodegenerative disorders and beyond. Curr. Med. Chem., 2011, 18(10), 1464-1475.
[17]
Meunier, B. Hybrid molecules with a dual mode of action: Dream or reality? Acc. Chem. Res., 2008, 41(1), 69-77.
[18]
Kant, R.; Kumar, D.; Agarwal, D.; Gupta, R.D.; Tilak, R.; Awasthi, S.K.; Agarwal, A. Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities. Eur. J. Med. Chem., 2016, 113, 34-49.
[19]
Rodríguez-Hernández, D.; Demuner, A.J.; Barbosa, L.C.A.; Heller, L.; Csuk, R. Novel hederagenin-triazolyl derivatives as potential anti-cancer agents. Eur. J. Med. Chem., 2016, 115, 257-267.
[20]
Keglevich, P.; Hazai, L.; Gorka-Kereskényi, Á.; Péter, L.; Gyenese, J.; Lengyel, Z.S.; Kalaus, G.Y.; Dubrovay, Z.S.; Dékány, M.; Orbán, E.; Szabó, I.; Bánóczi, Z.; Szántay, C.S., Jr; Szántay, C.S. Synthesis and in vitro antitumor effect of new vindoline derivatives coupled with amino acid esters. Heterocycles, 2013, 87(11), 2299-2317.
[21]
Bánóczi, Z.; Gorka-Kereskényi, Á.; Reményi, J.; Orbán, E.; Hazai, L.; Tökési, N.; Oláh, J.; Ovádi, J.; Béni, Z.; Háda, V.; Szántay, C., Jr; Hudecz, F.; Kalaus, G.; Szántay, C. Synthesis and in vitro antitumor effect of vinblastine derivative-oligoarginine conjugates. Bioconjug. Chem., 2010, 21(11), 1948-1955.
[22]
Bánóczi, Z.; Keglevich, A.; Szabó, I.; Ranđelović, I.; Hegedüs, Z.; Regenbach, F.L.; Keglevich, P.; Lengyel, Z.; Gorka-Kereskényi, Á.; Dubrovay, Z.; Háda, V.; Szigetvári, Á.; Szántay, C., Jr; Hazai, L.; Tóvári, J.; Hudecz, F. The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell-penetrating peptide. J. Pept. Sci., 2018, 24(10)e3118
[23]
Tsepaeva, O.V.; Nemtarev, A.V.; Abdullin, T.I.; Grigor’eva, L.R.; Kuznetsova, E.V.; Akhmadishina, R.A.; Ziganshina, L.E.; Cong, H.H.; Mironov, V.F. Design, Synthesis, and Cancer Cell Growth Inhibitory Activity of Triphenylphosphonium Derivatives of the Triterpenoid Betulin. J. Nat. Prod., 2017, 80(8), 2232-2239.
[24]
Passarella, D.; Giardini, A.; Peretto, B.; Fontana, G.; Sacchetti, A.; Silvani, A.; Ronchi, C.; Cappelletti, G.; Cartelli, D.; Borlak, J.; Danieli, B. Inhibitors of tubulin polymerization: Synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III. Bioorg. Med. Chem., 2008, 16(11), 6269-6285.
[25]
Keglevich, A.; Szigetvári, Á.; Dékány, M.; Szántay, Cs., Jr; Keglevich, P.; Hazai, L. Synthesis of vinca alkaloid–triphenylphosphine derivatives having potential antitumor effect. Phosph. Sulf. Sil. Rel. Elements, 2019, 1-4.
[26]
Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 1991, 83(11), 757-766.
[27]
Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 1988, 48(3), 589-601.
[28]
Shoemaker, R.H.; Monks, A.; Alley, M.C.; Scudiero, D.A.; Fine, D.L.; McLemore, T.L.; Abbott, B.J.; Paull, K.D.; Mayo, J.G.; Boyd, M.R. Development of human tumor cell line panels for use in disease-oriented drug screening. Prog. Clin. Biol. Res., 1988, 276, 265-286.
Download PDF Flyer